首页|卵巢癌组织lncRNA HCG18、miR-152-3p表达与临床病理特征及预后的关系研究

卵巢癌组织lncRNA HCG18、miR-152-3p表达与临床病理特征及预后的关系研究

扫码查看
目的:探讨卵巢癌组织中长链非编码核糖核酸(RNA)人类白细胞抗原复合体18(lncRNAHCG18)、微小RNA-152-3p(miR-152-3p)的表达情况与患者临床病理特征及预后的关系。方法:选择2016年1月至2021年1月我院收治的卵巢癌患者185例为研究对象。采用聚合酶链式反应(PCR)法检测并比较术中获取的卵巢癌组织与癌旁组织(距离癌组织边缘>2cm)lncRNA HCG18、miR-152-3p表达。分析lncRNAHCG18、miR-152-3p表达与卵巢癌患者临床病理特征之间的关系。对卵巢癌患者实施3年随访,采用Kaplan-Meier生存曲线比较lncRNA HCG18、miR-152-3p高表达、低表达的卵巢癌患者3年累积生存率。采用Cox风险模型分析卵巢癌患者预后的影响因素。结果:lncRNA HCG18表达水平比较,卵巢癌组织高于癌旁组织(P<0。05),miR-152-3p表达水平比较,卵巢癌组织低于癌旁组织(P<0。05)。卵巢癌组织中lncRNA HCG18、miR-152-3p表达水平与国际妇产科联盟(FIGO)分期、分化程度、腹腔积液、淋巴结转移有关(P<0。05)。高lncRNA HCG18组3年累积生存率为41。57%(37/89),低于低lncRNA HCG18组的70。65%(65/92),差异有统计学意义(P<0。05);高miR-152-3p组3年累积生存率75。53%(71/94),高于低miR-152-3p组的35。63%(31/87),差异有统计学意义(P<0。05)。Cox比例风险模型分析结果显示,FIGO分期Ⅲ~Ⅳ期、分化程度为高、中分化、腹腔积液、淋巴结转移、lncRNAHCG18升高,miR-152-3p降低是卵巢癌患者预后不良的危险因素。结论:卵巢癌组织中lncRNAHCG18高表达,miR-152-3p低表达与恶性临床病理特征及预后不良的发生有关。
Study on the Relationship between the Expression of lncRNA HCG18 and miR-152-3p in Ovarian Cancer Tissues and Clinicopathological Features and Prognosis
Objective:To investigate the expression of long non-coding ribonucleic acids(lncRNA)human leukocyte antigen complex group 18(lncRNA HCG18)and microRNA-152-3p(miR-152-3p)in ovarian cancer tissues and their relationship with clinicopathological features and prognosis of patients.Methods:185 ovarian cancer patients admitted to our hospital from January 2016 to January 2021 were selected as the study subjects.The expression of lncRNA HCG18 and miR-152-3p in ovarian cancer tissues and adjacent tissues(≥ 2 cm from the edge of cancer tissues)were detected and compared by polymerase chain reaction(PCR).The relationship between the expression of lncRNA HCG18,miR-152-3p and the clinicopathological features of ovarian cancer patients was analyzed.Ovarian cancer patients were followed up for 3 years,the 3 years cumulative survival rate in ovarian cancer patients with high expression and low expression of lncRNA HCG18 and miR-152-3p were compared by Kaplan-Meier survival curve.The prognostic factors of ovarian cancer patients were analyzed by Cox risk model was used to analyze.Results:Comparison of the expression levels of lncRNA HCG18,ovarian cancer tissues was higher than that of adjacent tissues(P<0.05),and Comparison of the expression levels of miR-152-3p,ovarian cancer tissues was lower than that of adjacent tissues(P<0.05).The expression levels of lncRNA HCG18 and miR-152-3p in ovarian cancer tissues were related to International Federation of Gynecology and Obstetrics(FIGO)stage,degree of differentiation,ascites and lymph node metastasis(P<0.05).The 3 years cumulative survival rate in high lncRNA HCG18 group was 41.57%(37/89),which was lower than 70.65%(65/92)in low lncRNA HCG18 group,there was a difference of statistical significance(P<0.05).The 3 years cumulative survival rate in high miR-152-3p group was 75.53%(71/94),which was higher than 35.63%(31/87)in low miR-152-3p group,there was a difference of statistical significance(P<0.05).Cox proportional hazard model analysis showed that,FIGO stage Ⅲ~IV,high and moderate differentiation,ascites,lymph node metastasis,lncRNA HCG18 increased,miR-152-3p decreased were risk factors for poor prognosis in ovarian cancer patients.Conclusion:The high expression of lncRNA HCG18 and the low expression of miR-152-3p in ovarian cancer tissues are relate to the occurrence of malignant clinicopathological features and poor prognosis.

Ovarian cancerlncRNA HCG18miR-152-3pPathological featuresPrognosis

蒋莎、陈畅乾、卢娟、陈惠惠、康旻

展开 >

珠海市中西医结合医院(南方医科大学附属珠海医院)妇科 广东珠海 519000

卵巢癌 lncRNA HCG18 miR-152-3p 病理特征 预后

珠海市社会发展领域科技计划项目珠海市社会发展领域科技计划项目广东省自然科学基金面上项目

2320000040000287222000400001982023A1515010515

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(17)